Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine and Apixaban in COVID-19
NCT04788355Phase 3Completed
- Sponsor
- Universidade do Vale do Sapucaí
- Start
- Jul 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxychloroquine, apixaban in coronavirus disease 2019 (COVID-19), sponsored by Universidade do Vale do Sapucaí. Started Jul 2020; status: completed.
02
Drugs
hydroxychloroquineapixaban
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04788355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04788355.